AC-262536
AC-262536 is a drug developed by Acadia Pharmaceuticals that acts as a selective androgen receptor modulator (SARM). Chemically, it possesses endo-exo isomerism, with the endo form being the active form.
It acts as a partial agonist for the androgen receptor with a Ki of 5 nM and no significant affinity for other receptors tested.
In animal studies, it produced a maximum effect of about 66% of the anabolic effect of testosterone, and only about 27% of its potency as an androgen
Concentration
10mg/ml.
DISCLAIMER
This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary or domestic use. Please familiarize yourself with our DISCLAIMER before ordering.
Included is a precision pipette marked per 0.2 ml!
Data sheet
AC-262536 – Solution, 300mg (10mg/mL)
| Application | SARM, AR partial agonist |
| CAS | 870888-46-3 |
| Molar Mass | 278.348 g/mol |
| Chemical Formula | C18H18N2O |
| IUPAC Name | 4-(3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)naphthalene-1-carbonitrile |
| Synonyms | AC-262,536, AC-262536, CHEMBL468938, SCHEMBL4879629 |
| Storage | Room temperature |
| Solubility | Soluble in DMSO |
| Organoleptic Profile | Clear Liquid |
| Physical Form | Solution in DMSO, PEG400 |
| Specification | 10mg/mL ±5% |
| Terms | This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. |